Laura G Slippy, NP
Nurse Practitioner · Salinas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Offices
- 2
Offices
2 locations · Doctors on Duty Medical Group, Inc · Thinh Duy Mai MD Apc
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Laura G Slippy’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence G11619 · Cancelled
Licence status: Cancelled · since 1966 · Harvard Medical School.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$17,595
Medicare paid this office $17,595 for 50 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 27 | $8,102 | $123 |
| Return visit (30+ min) | 38 | $6,710 | $78 |
| Psychotherapy with evaluation and management visit, 30 minutes | 13 | $596 | $43 |
Who their Medicare patients are
50 Original Medicare patients in 2024. Average age 62 · Women 66% · Also on Medicaid 70% · Health risk score 1.14. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 52% · Depression 50% · Diabetes 28%.
The office billed $43,465, Medicare allowed $24,497 and paid $17,595; for 202 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 50 | 202 | 62 | 1.14 | $43,465 | $17,595 |
| 2023 | 46 | 181 | 61 | 0.86 | $34,183 | $13,633 |
| 2022 | 38 | 222 | 57 | 0.70 | $36,155 | $14,472 |
| 2021 | 41 | 111 | 63 | 1.01 | $18,673 | $7,924 |
| 2020 | 36 | 109 | 65 | 0.99 | $19,851 | $7,471 |
| 2019 | 32 | 97 | 65 | 0.70 | $14,900 | $5,381 |
| 2017 | 19 | 34 | 54 | 1.19 | $3,965 | $1,188 |
| 2016 | 49 | 152 | 54 | 1.47 | $17,170 | $7,742 |
| 2015 | 37 | 127 | 53 | 0.98 | $13,610 | $6,156 |
| 2013 | 154 | 676 | 74 | 1.14 | $47,867 | $17,772 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 33 | $6,489 | $84 |
| New patient visit (60+ min) | 16 | $2,361 | $148 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,827 | $65 |
| Psychotherapy with evaluation and management visit, 30 minutes | 22 | $1,253 | $39 |
2022: 5 services
| Telephone medical discussion with physician, 21-30 minutes | 20 | $5,045 | $92 |
| Return visit (30+ min) | 23 | $3,897 | $67 |
| Psychotherapy with evaluation and management visit, 30 minutes | 21 | $3,253 | $51 |
| New patient visit (60+ min) | 11 | $1,216 | $111 |
| Annual alcohol misuse screening, 5 to 15 minutes | 18 | $317 | $17 |
2021: 2 services
| Return visit (30+ min) | 27 | $4,211 | $83 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $2,499 | $86 |
2020: 1 service
| Return visit (30+ min) | 22 | $4,343 | $74 |
2019: 1 service
| Return visit (30+ min) | 24 | $4,171 | $73 |
2017: 1 service
| Short return visit (20+ min) | 14 | $506 | $28 |
2016: 3 services
| Short return visit (20+ min) | 42 | $4,094 | $44 |
| Return visit (30+ min) | 20 | $2,002 | $61 |
| Psychiatric diagnostic evaluation with medical services | 12 | $1,025 | $85 |
2015: 3 services
| Short return visit (20+ min) | 35 | $3,707 | $44 |
| Return visit (30+ min) | 11 | $1,151 | $68 |
| Psychotherapy with evaluation and management visit, 30 minutes | 15 | $716 | $40 |
2013: 15 services
| Short return visit (20+ min) | 118 | $6,892 | $48 |
| Return visit (30+ min) | 20 | $1,393 | $70 |
| Test to determine lung volumes using sensors | 18 | $780 | $43 |
| Blood test, thyroid stimulating hormone (tsh) | 27 | $611 | $23 |
| Natriuretic peptide (heart and blood vessel protein) level | 12 | $594 | $46 |
| X-ray of chest, 2 views, front and side | 23 | $502 | $21 |
| Blood test, comprehensive group of blood chemicals | 35 | $494 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 37 | $398 | $10 |
| Cyanocobalamin (vitamin b-12) level | 18 | $366 | $20 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 11 | $236 | $21 |
| Evaluation of use of breathing device | 17 | $228 | $13 |
| Manual urinalysis test with examination using microscope, non-automated | 37 | $187 | $4 |
| Bacterial colony count, urine | 16 | $185 | $11 |
| Ldl cholesterol level | 14 | $180 | $13 |
| Insertion of needle into vein for collection of blood sample | 56 | $176 | $3 |
Medicaid work
$0 in 2022
Medicaid paid $0 for 15 billed services this clinician did in 2022, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | 15 | $0 |
| 2022 | 15 | 1 | 15 | $0 |
Drugs they prescribed that Part D paid
$271,028
Pharmacies billed $271,028 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 863) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
729 generic and 134 brand-name prescriptions · $271,028 in drug cost · 43 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 29 | $41,423 | $1,428 |
| Vraylar | 20 | $37,890 | $1,894 |
| Desvenlafaxine Succinate Er | 34 | $2,364 | $70 |
| Albuterol Sulfate Hfa | 16 | $917 | $57 |
| Hydroxyzine | 11 | $843 | $77 |
See all 29 drugs
| Ozempic | 29 | $41,423 | $1,428 |
| Vraylar | 20 | $37,890 | $1,894 |
| Desvenlafaxine Succinate Er | 34 | $2,364 | $70 |
| Albuterol Sulfate Hfa | 16 | $917 | $57 |
| Hydroxyzine | 11 | $843 | $77 |
| Pregabalin | 28 | $814 | $29 |
| Mirtazapine | 18 | $814 | $45 |
| Olanzapine | 11 | $648 | $59 |
| Trazodone | 45 | $644 | $14 |
| Gabapentin | 36 | $584 | $16 |
| Bupropion Hcl Sr | 13 | $570 | $44 |
| Quetiapine | 18 | $502 | $28 |
| Modafinil | 11 | $482 | $44 |
| Zolpidem Tartrate Er | 11 | $424 | $39 |
| Venlafaxine Hcl Er | 13 | $409 | $31 |
| Buspirone | 32 | $408 | $13 |
| Risperidone | 13 | $360 | $28 |
| Prazosin | 12 | $350 | $29 |
| Bupropion Xl | 13 | $339 | $26 |
| Propranolol | 17 | $321 | $19 |
| Amitriptyline | 13 | $257 | $20 |
| Methylphenidate | 12 | $243 | $20 |
| Clonazepam | 15 | $212 | $14 |
| Lamotrigine | 20 | $140 | $7 |
| Topiramate | 20 | $107 | $5 |
| Lorazepam | 33 | $104 | $3 |
| Zolpidem | 33 | $96 | $3 |
| Clonidine | 11 | $88 | $8 |
| Alprazolam | 15 | $21 | $1 |
Year by year
| 2024 | 863 | 51 | 0% (0) | 16% | $271,028 |
| 2023 | 690 | 47 | 0% (0) | 20% | $161,646 |
| 2022 | 638 | 45 | 0% (0) | 10% | $88,625 |
| 2021 | 480 | 35 | 0% (0) | 4% | $31,456 |
| 2020 | 342 | 35 | 0% (0) | None | $10,738 |
| 2019 | 217 | 42 | 0% (0) | None | $7,886 |
| 2018 | 1,085 | 133 | None | 17% | $123,904 |
| 2017 | 1,131 | 118 | 0% (0) | 16% | $116,197 |
| 2016 | 659 | 64 | 0% (0) | 15% | $73,687 |
| 2015 | 680 | 99 | 0% (0) | 20% | $77,984 |
| 2014 | 1,440 | 241 | 8% (109) | None | $125,089 |
| 2013 | 1,544 | 321 | 12% (192) | None | $119,750 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Vraylar | 26 | $38,665 | $1,487 |
| Rexulti | 11 | $20,586 | $1,871 |
| Ozempic | 12 | $11,936 | $995 |
| Asenapine Maleate | 13 | $11,358 | $874 |
| Fetzima | 22 | $11,341 | $515 |
| Pregabalin | 12 | $1,831 | $153 |
| Desvenlafaxine Succinate Er | 12 | $1,742 | $145 |
| Quetiapine | 34 | $1,504 | $44 |
| Hydroxyzine | 15 | $1,312 | $87 |
| Risperidone | 20 | $958 | $48 |
| Trazodone | 27 | $942 | $35 |
| Buspirone | 30 | $936 | $31 |
| Zolpidem | 35 | $630 | $18 |
| Eszopiclone | 11 | $601 | $55 |
| Methylphenidate | 12 | $582 | $49 |
| Mirtazapine | 11 | $557 | $51 |
| Bupropion Hcl Sr | 11 | $508 | $46 |
| Gabapentin | 21 | $407 | $19 |
| Topiramate | 18 | $398 | $22 |
| Montelukast | 13 | $376 | $29 |
| Sertraline | 18 | $332 | $18 |
| Clonazepam | 22 | $263 | $12 |
| Lamotrigine | 14 | $248 | $18 |
| Lithium Carbonate | 21 | $197 | $9 |
| Fluoxetine | 13 | $197 | $15 |
| Lorazepam | 18 | $171 | $10 |
2022: 24 drugs
| Latuda | 25 | $38,082 | $1,523 |
| Vraylar | 13 | $17,819 | $1,371 |
| Quetiapine | 47 | $6,285 | $134 |
| Aripiprazole | 29 | $3,310 | $114 |
| Desvenlafaxine Succinate Er | 15 | $2,117 | $141 |
| Bupropion Xl | 16 | $964 | $60 |
| Eszopiclone | 28 | $920 | $33 |
| Bupropion Hcl Sr | 15 | $768 | $51 |
| Gabapentin | 45 | $478 | $11 |
| Dextroamphetamine-Amphetamine | 11 | $475 | $43 |
| Trazodone | 22 | $376 | $17 |
| Doxepin | 12 | $342 | $29 |
| Zolpidem | 28 | $330 | $12 |
| Benztropine Mesylate | 12 | $308 | $26 |
| Propranolol | 20 | $280 | $14 |
| Buspirone | 27 | $271 | $10 |
| Topiramate | 15 | $224 | $15 |
| Risperidone | 16 | $179 | $11 |
| Sertraline | 11 | $171 | $16 |
| Fluoxetine | 19 | $134 | $7 |
| Lorazepam | 27 | $98 | $4 |
| Clonazepam | 25 | $85 | $3 |
| Clonidine | 13 | $74 | $6 |
| Diazepam | 12 | $14 | $1 |
2021: 17 drugs
| Latuda | 11 | $15,600 | $1,418 |
| Aripiprazole | 43 | $3,087 | $72 |
| Mirtazapine | 22 | $816 | $37 |
| Quetiapine | 27 | $664 | $25 |
| Buspirone | 43 | $599 | $14 |
| Bupropion Xl | 17 | $555 | $33 |
| Desvenlafaxine Succinate Er | 11 | $502 | $46 |
| Eszopiclone | 17 | $485 | $29 |
| Topiramate | 14 | $457 | $33 |
| Bupropion Hcl Sr | 17 | $435 | $26 |
| Gabapentin | 25 | $377 | $15 |
| Fluoxetine | 24 | $312 | $13 |
| Zolpidem | 28 | $293 | $10 |
| Trazodone | 21 | $237 | $11 |
| Sertraline | 16 | $67 | $4 |
| Clonazepam | 17 | $30 | $2 |
| Lorazepam | 11 | $17 | $2 |
2020: 10 drugs
| Aripiprazole | 25 | $3,792 | $152 |
| Gabapentin | 19 | $636 | $33 |
| Mirtazapine | 11 | $500 | $45 |
| Buspirone | 39 | $433 | $11 |
| Bupropion Xl | 20 | $404 | $20 |
| Duloxetine | 16 | $385 | $24 |
| Topiramate | 13 | $171 | $13 |
| Sertraline | 24 | $84 | $4 |
| Trazodone | 11 | $70 | $6 |
| Clonazepam | 11 | $55 | $5 |
2019: 6 drugs
| Gabapentin | 24 | $333 | $14 |
| Buspirone | 19 | $251 | $13 |
| Quetiapine | 14 | $144 | $10 |
| Mirtazapine | 11 | $93 | $8 |
| Fluoxetine | 15 | $91 | $6 |
| Clonazepam | 13 | $17 | $1 |
2018: 33 drugs
| Vraylar | 14 | $17,947 | $1,282 |
| Trintellix | 26 | $13,965 | $537 |
| Oxtellar Xr | 13 | $12,051 | $927 |
| Paliperidone Er | 13 | $8,739 | $672 |
| Vyvanse | 24 | $7,490 | $312 |
| Desvenlafaxine Succinate Er | 68 | $7,104 | $104 |
| Duloxetine | 25 | $3,954 | $158 |
| Viibryd | 11 | $3,250 | $295 |
| Bupropion Xl | 38 | $1,691 | $44 |
| Dextroamphetamine-Amphetamine | 28 | $1,304 | $47 |
| Prazosin | 32 | $1,206 | $38 |
| Hydroxyzine Pamoate | 17 | $893 | $53 |
| Gabapentin | 46 | $807 | $18 |
| Lamotrigine | 54 | $661 | $12 |
| Buspirone | 41 | $609 | $15 |
| Mirtazapine | 55 | $604 | $11 |
| Zolpidem Tartrate Er | 11 | $567 | $52 |
| Doxepin | 12 | $522 | $43 |
| Venlafaxine Hcl Er | 24 | $488 | $20 |
| Oxcarbazepine | 22 | $481 | $22 |
| Ipratropium | 13 | $451 | $35 |
| Lorazepam | 47 | $400 | $9 |
| Quetiapine | 34 | $388 | $11 |
| Zolpidem | 36 | $349 | $10 |
| Temazepam | 11 | $341 | $31 |
| Trazodone | 29 | $288 | $10 |
| Metoprolol | 14 | $269 | $19 |
| Benztropine Mesylate | 22 | $226 | $10 |
| Clonazepam | 23 | $203 | $9 |
| Amitriptyline | 11 | $179 | $16 |
| Alprazolam | 24 | $173 | $7 |
| Escitalopram | 16 | $153 | $10 |
| Sertraline | 14 | $140 | $10 |
2017: 35 drugs
| Rexulti | 14 | $15,277 | $1,091 |
| Nuedexta | 15 | $13,998 | $933 |
| Vraylar | 12 | $12,820 | $1,068 |
| Trintellix | 20 | $8,148 | $407 |
| Vyvanse | 26 | $7,526 | $289 |
| Pristiq | 12 | $6,792 | $566 |
| Desvenlafaxine Succinate Er | 46 | $5,584 | $121 |
| Aripiprazole | 17 | $3,616 | $213 |
| Viibryd | 13 | $3,371 | $259 |
| Duloxetine | 39 | $2,405 | $62 |
| Bupropion Xl | 46 | $1,901 | $41 |
| Prazosin | 33 | $1,731 | $52 |
| Gabapentin | 68 | $1,494 | $22 |
| Dextroamphetamine-Amphetamine | 27 | $974 | $36 |
| Zolpidem Tartrate Er | 11 | $909 | $83 |
| Quetiapine | 43 | $723 | $17 |
| Oxcarbazepine | 24 | $593 | $25 |
| Eszopiclone | 19 | $586 | $31 |
| Lamotrigine | 60 | $538 | $9 |
| Trazodone | 39 | $448 | $11 |
| Mirtazapine | 41 | $426 | $10 |
| Zolpidem | 55 | $396 | $7 |
| Venlafaxine Hcl Er | 27 | $376 | $14 |
| Alprazolam | 45 | $320 | $7 |
| Lorazepam | 54 | $319 | $6 |
| Clonazepam | 28 | $310 | $11 |
| Metoprolol | 12 | $300 | $25 |
| Buspirone | 18 | $245 | $14 |
| Sertraline | 23 | $213 | $9 |
| Temazepam | 17 | $177 | $10 |
| Divalproex | 11 | $151 | $14 |
| Paroxetine | 17 | $143 | $8 |
| Escitalopram | 19 | $140 | $7 |
| Benztropine Mesylate | 15 | $74 | $5 |
| Clonidine | 12 | $53 | $4 |
2016: 25 drugs
| Seroquel Xr | 15 | $13,155 | $877 |
| Abilify | 11 | $9,843 | $895 |
| Bupropion Xl | 35 | $987 | $28 |
| Gabapentin | 29 | $923 | $32 |
| Oxcarbazepine | 19 | $837 | $44 |
| Prazosin | 18 | $765 | $43 |
| Eszopiclone | 16 | $467 | $29 |
| Metoprolol | 17 | $461 | $27 |
| Escitalopram | 26 | $459 | $18 |
| Haloperidol | 16 | $399 | $25 |
| Quetiapine | 11 | $280 | $25 |
| Olanzapine | 23 | $268 | $12 |
| Venlafaxine Hcl Er | 24 | $201 | $8 |
| Lamotrigine | 21 | $186 | $9 |
| Trazodone | 27 | $179 | $7 |
| Sertraline | 18 | $167 | $9 |
| Topiramate | 24 | $151 | $6 |
| Alprazolam | 28 | $136 | $5 |
| Benztropine Mesylate | 15 | $106 | $7 |
| Buspirone | 13 | $97 | $7 |
| Fluoxetine | 13 | $96 | $7 |
| Lorazepam | 27 | $87 | $3 |
| Risperidone | 11 | $81 | $7 |
| Zolpidem | 30 | $65 | $2 |
| Clonidine | 15 | $54 | $4 |
2015: 23 drugs
| Abilify | 20 | $18,002 | $900 |
| Seroquel Xr | 22 | $14,593 | $663 |
| Latuda | 12 | $11,282 | $940 |
| Venlafaxine Hcl Er | 29 | $1,170 | $40 |
| Bupropion Xl | 28 | $1,147 | $41 |
| Omeprazole | 16 | $722 | $45 |
| Escitalopram | 18 | $415 | $23 |
| Quetiapine | 21 | $370 | $18 |
| Olanzapine | 21 | $271 | $13 |
| Gabapentin | 17 | $222 | $13 |
| Fluoxetine | 22 | $188 | $9 |
| Zolpidem | 21 | $162 | $8 |
| Lorazepam | 14 | $154 | $11 |
| Sertraline | 20 | $151 | $8 |
| Trazodone | 25 | $140 | $6 |
| Alprazolam | 30 | $110 | $4 |
| Paroxetine | 13 | $106 | $8 |
| Topiramate | 11 | $106 | $10 |
| Benztropine Mesylate | 11 | $106 | $10 |
| Clonazepam | 23 | $104 | $5 |
| Clonidine | 20 | $90 | $5 |
| Bupropion Hcl Sr | 12 | $87 | $7 |
| Mirtazapine | 12 | $81 | $7 |
2014: 36 drugs
| Nuvigil | 20 | $10,007 | $500 |
| Diovan | 11 | $4,268 | $388 |
| Qvar | 11 | $3,285 | $299 |
| Bupropion Xl | 24 | $2,444 | $102 |
| Escitalopram | 48 | $1,997 | $42 |
| Proair Hfa | 29 | $1,742 | $60 |
| Levothyroxine | 61 | $1,653 | $27 |
| Omeprazole | 57 | $1,565 | $27 |
| Atorvastatin | 37 | $1,034 | $28 |
| Ipratropium | 41 | $999 | $24 |
| Voltaren | 19 | $787 | $41 |
| Synthroid | 11 | $669 | $61 |
| Hydrocodone-Acetaminophen | 39 | $602 | $15 |
| Tramadol | 37 | $594 | $16 |
| Fluoxetine | 20 | $428 | $21 |
| Methadone | 20 | $384 | $19 |
| Losartan | 30 | $370 | $12 |
| Topiramate | 21 | $328 | $16 |
| Triamterene-Hydrochlorothiazid | 23 | $326 | $14 |
| Atenolol | 18 | $298 | $17 |
| Levofloxacin | 25 | $287 | $11 |
| Losartan-Hydrochlorothiazide | 12 | $228 | $19 |
| Meloxicam | 40 | $220 | $6 |
| Amlodipine Besylate | 19 | $187 | $10 |
| Azithromycin | 21 | $176 | $8 |
| Lisinopril | 24 | $171 | $7 |
| Clonazepam | 19 | $164 | $9 |
| Simvastatin | 13 | $157 | $12 |
| Verapamil Er | 11 | $147 | $13 |
| Ciprofloxacin | 11 | $120 | $11 |
| Quetiapine | 13 | $119 | $9 |
| Metformin | 14 | $112 | $8 |
| Hydrochlorothiazide | 16 | $102 | $6 |
| Cyclobenzaprine | 11 | $97 | $9 |
| Alprazolam | 17 | $94 | $6 |
| Trazodone | 14 | $79 | $6 |
2013: 40 drugs
| Nuvigil | 16 | $9,803 | $613 |
| Oxycontin | 11 | $7,254 | $659 |
| Advair Diskus | 13 | $4,950 | $381 |
| Diovan | 17 | $4,306 | $253 |
| Escitalopram | 39 | $2,784 | $71 |
| Qvar | 14 | $2,115 | $151 |
| Omeprazole | 39 | $1,840 | $47 |
| Proair Hfa | 39 | $1,813 | $46 |
| Ipratropium | 89 | $1,777 | $20 |
| Gabapentin | 20 | $1,159 | $58 |
| Tramadol | 56 | $973 | $17 |
| Nitrofurantoin Mono-Macro | 17 | $949 | $56 |
| Oxycodone Hcl-Acetaminophen | 13 | $864 | $66 |
| Amlodipine Besylate-Benazepril | 12 | $772 | $64 |
| Azithromycin | 73 | $734 | $10 |
| Atorvastatin | 21 | $691 | $33 |
| Hydrocodone-Acetaminophen | 60 | $644 | $11 |
| Levofloxacin | 45 | $473 | $11 |
| Synthroid | 12 | $392 | $33 |
| Atenolol | 27 | $371 | $14 |
| Methadone | 31 | $353 | $11 |
| Losartan | 26 | $348 | $13 |
| Amlodipine Besylate | 28 | $342 | $12 |
| Ciprofloxacin | 44 | $333 | $8 |
| Fluoxetine | 15 | $289 | $19 |
| Levothyroxine | 15 | $282 | $19 |
| Losartan-Hydrochlorothiazide | 15 | $244 | $16 |
| Lisinopril | 19 | $238 | $13 |
| Fluconazole | 11 | $199 | $18 |
| Estradiol | 15 | $193 | $13 |
| Meloxicam | 28 | $162 | $6 |
| Triamterene-Hctz | 11 | $158 | $14 |
| Metformin | 12 | $153 | $13 |
| Cephalexin | 14 | $148 | $11 |
| Sertraline | 13 | $117 | $9 |
| Hydrochlorothiazide | 18 | $102 | $6 |
| Furosemide | 20 | $78 | $4 |
| Alprazolam | 12 | $78 | $6 |
| Warfarin | 11 | $75 | $7 |
| Prednisone | 13 | $42 | $3 |
Money from drug and device companies
$4,329 in 2025
| 2025 | 18 | 259 | None | $4,329 |
| 2024 | 15 | 170 | None | $2,888 |
| 2023 | 14 | 144 | None | $2,313 |
| 2022 | 14 | 112 | None | $2,029 |
| 2021 | 8 | 79 | None | $1,254 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Axsome Therapeutics | Auvelity | $969 | 36 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $689 | 54 payments
|
| Abbvie | Vraylar | $487 | 49 payments
|
| Vanda Pharmaceuticals | Fanapt | $412 | 21 payments
|
| Alkermes | Aristada | $397 | 30 payments
|
| Neurocrine BioSciences | Ingrezza | $281 | 14 payments
|
See all 259 published payments
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-29 | Caplyta | $6 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-29 | Caplyta | $7 |
| Axsome Therapeutics | Meals · 2025-12-23 | Auvelity | $32 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-23 | Caplyta | $12 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-18 | Caplyta | $15 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-18 | Caplyta | $10 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-18 | Caplyta | $3 |
| Abbvie | Meals · 2025-12-16 | Vraylar | $6 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-11 | Cobenfy | $25 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-12-11 | Trintellix | $24 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-09 | Caplyta | $28 |
| Abbvie | Meals · 2025-12-08 | Vraylar | $10 |
| Abbvie | Meals · 2025-12-08 | Qulipta | $8 |
| Alkermes | Meals · 2025-12-08 | Aristada | $12 |
| Axsome Therapeutics | Meals · 2025-12-05 | Auvelity | $35 |
| Vanda Pharmaceuticals | Meals · 2025-12-04 | Fanapt | $6 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-04 | Caplyta | $6 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-04 | Caplyta | $2 |
| Tris Pharma | Meals · 2025-12-03 | Dyanavel Xr | $3 |
| Tris Pharma | Meals · 2025-12-03 | Dyanavel Xr | $12 |
| Abbvie | Meals · 2025-12-03 | Vraylar | $5 |
| Pfizer | Meals · 2025-12-03 | Nurtec Odt | $17 |
| Abbvie | Meals · 2025-12-01 | Vraylar | $9 |
| Otsuka America Pharmaceutical | Meals · 2025-11-20 | Rexulti | $23 |
| Axsome Therapeutics | Meals · 2025-11-20 | Auvelity | $27 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-19 | Caplyta | $8 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-18 | Cobenfy | $13 |
| Axsome Therapeutics | Meals · 2025-11-18 | Sunosi | $22 |
| Abbvie | Meals · 2025-11-17 | Vraylar | $5 |
| Axsome Therapeutics | Meals · 2025-11-13 | Auvelity | $35 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-13 | Caplyta | $11 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-12 | Cobenfy | $10 |
| Abbvie | Meals · 2025-11-12 | Vraylar | $2 |
| Alkermes | Meals · 2025-11-12 | Aristada | $12 |
| Vanda Pharmaceuticals | Meals · 2025-11-11 | Fanapt | $35 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-11 | Caplyta | $4 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-11 | Caplyta | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-06 | Cobenfy | $16 |
| Abbvie | Meals · 2025-11-06 | Vraylar | $7 |
| Abbvie | Meals · 2025-11-03 | Vraylar | $8 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-03 | Caplyta | $21 |
| Abbvie | Meals · 2025-10-29 | Vraylar | $8 |
| Alkermes | Meals · 2025-10-29 | Aristada | $12 |
| Axsome Therapeutics | Meals · 2025-10-29 | Auvelity | $34 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-29 | Caplyta | $2 |
| Vanda Pharmaceuticals | Meals · 2025-10-27 | Fanapt | $4 |
| Vanda Pharmaceuticals | Meals · 2025-10-27 | Fanapt | $20 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-27 | Caplyta | $23 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-23 | Caplyta | $19 |
| Tris Pharma | Meals · 2025-10-22 | Dyanavel Xr | $10 |
| Abbvie | Meals · 2025-10-22 | Qulipta | $11 |
| Abbvie | Meals · 2025-10-22 | Qulipta | $7 |
| Axsome Therapeutics | Meals · 2025-10-22 | Sunosi | $99 |
| Otsuka America Pharmaceutical | Meals · 2025-10-21 | Rexulti | $12 |
| Otsuka America Pharmaceutical | Meals · 2025-10-21 | Rexulti | $22 |
| Abbvie | Meals · 2025-10-20 | Vraylar | $7 |
| Axsome Therapeutics | Meals · 2025-10-20 | Sunosi | $24 |
| Axsome Therapeutics | Meals · 2025-10-17 | Auvelity | $34 |
| Neurocrine BioSciences | Meals · 2025-10-16 | Ingrezza | $18 |
| Alkermes | Meals · 2025-10-15 | Aristada | $10 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-13 | Caplyta | $31 |
| Indivior | Meals · 2025-10-09 | Sublocade | $16 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-09 | Caplyta | $9 |
| Abbvie | Meals · 2025-10-08 | Vraylar | $6 |
| Axsome Therapeutics | Meals · 2025-10-08 | Auvelity | $35 |
| Pfizer | Meals · 2025-10-07 | Nurtec Odt | $21 |
| Vanda Pharmaceuticals | Meals · 2025-10-06 | Fanapt | $8 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-06 | Caplyta | $25 |
| Abbvie | Meals · 2025-10-01 | Vraylar | $21 |
| Pfizer | Meals · 2025-10-01 | Nurtec Odt | $18 |
| Abbvie | Meals · 2025-09-30 | Qulipta | $18 |
| Alkermes | Meals · 2025-09-29 | Aristada | $8 |
| Tris Pharma | Meals · 2025-09-26 | Dyanavel Xr | $25 |
| Neurocrine BioSciences | Meals · 2025-09-25 | Ingrezza | $16 |
| Abbvie | Meals · 2025-09-24 | Vraylar | $7 |
| Vertex Pharmaceuticals | Meals · 2025-09-24 | Journavx | $17 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-24 | Caplyta | $11 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-24 | Caplyta | $4 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-09-23 | Abilify Asimtufii | $28 |
| Otsuka America Pharmaceutical | Meals · 2025-09-23 | Rexulti | $16 |
| Abbvie | Meals · 2025-09-17 | Vraylar | $7 |
| Alkermes | Meals · 2025-09-16 | Aristada | $7 |
| Vanda Pharmaceuticals | Meals · 2025-09-16 | Fanapt | $39 |
| Abbvie | Meals · 2025-09-15 | Vraylar | $8 |
| Alkermes | Meals · 2025-09-11 | Lybalvi | $110 |
| Abbvie | Meals · 2025-09-10 | Vraylar | $11 |
| Alkermes | Meals · 2025-09-04 | Aristada | $5 |
| Abbvie | Meals · 2025-09-02 | Vraylar | $6 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-27 | Caplyta | $88 |
| Abbvie | Meals · 2025-08-26 | Vraylar | $6 |
| Pfizer | Meals · 2025-08-26 | Nurtec Odt | $16 |
| Alkermes | Meals · 2025-08-20 | Aristada | $8 |
| Axsome Therapeutics | Meals · 2025-08-20 | Auvelity | $20 |
| Abbvie | Meals · 2025-08-18 | Vraylar | $4 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-14 | Caplyta | $23 |
| Axsome Therapeutics | Meals · 2025-08-12 | Auvelity | $30 |
| Vanda Pharmaceuticals | Meals · 2025-08-11 | Fanapt | $16 |
| Vanda Pharmaceuticals | Meals · 2025-08-11 | Fanapt | $9 |
| Axsome Therapeutics | Meals · 2025-08-08 | Auvelity | $35 |
| Neurocrine BioSciences | Meals · 2025-08-07 | Ingrezza | $17 |
| Alkermes | Meals · 2025-08-06 | Aristada | $9 |
| Vanda Pharmaceuticals | Meals · 2025-08-06 | Fanapt | $13 |
| Axsome Therapeutics | Meals · 2025-08-05 | Sunosi | $17 |
| Abbvie | Meals · 2025-08-04 | Vraylar | $15 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-04 | Caplyta | $5 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-04 | Caplyta | $9 |
| Axsome Therapeutics | Meals · 2025-08-01 | Auvelity | $32 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-31 | Caplyta | $10 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-30 | Cobenfy | $13 |
| Axsome Therapeutics | Meals · 2025-07-28 | Sunosi | $32 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-07-24 | Trintellix | $37 |
| Otsuka America Pharmaceutical | Meals · 2025-07-24 | Rexulti | $34 |
| Vanda Pharmaceuticals | Meals · 2025-07-23 | Fanapt | $9 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-23 | Caplyta | $17 |
| Abbvie | Meals · 2025-07-22 | Vraylar | $6 |
| Axsome Therapeutics | Meals · 2025-07-18 | Auvelity | $6 |
| Neurocrine BioSciences | Meals · 2025-07-18 | Ingrezza | $33 |
| Axsome Therapeutics | Meals · 2025-07-17 | Auvelity | $8 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-16 | Caplyta | $19 |
| Pfizer | Meals · 2025-07-14 | Nurtec Odt | $16 |
| Vanda Pharmaceuticals | Meals · 2025-07-14 | Fanapt | $27 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-10 | Caplyta | $13 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-09 | Cobenfy | $19 |
| Alkermes | Meals · 2025-07-09 | Aristada | $5 |
| Axsome Therapeutics | Meals · 2025-07-09 | Sunosi | $24 |
| Abbvie | Meals · 2025-07-08 | Vraylar | $10 |
| Axsome Therapeutics | Meals · 2025-07-08 | Auvelity | $23 |
| Indivior | Meals · 2025-07-03 | Sublocade | $25 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-02 | Caplyta | $8 |
| Alkermes | Meals · 2025-07-01 | Aristada | $12 |
| Vanda Pharmaceuticals | Meals · 2025-07-01 | Fanapt | $30 |
| Axsome Therapeutics | Meals · 2025-07-01 | Sunosi | $16 |
| Vanda Pharmaceuticals | Meals · 2025-06-30 | Fanapt | $28 |
| Axsome Therapeutics | Meals · 2025-06-26 | Auvelity | $32 |
| Vanda Pharmaceuticals | Meals · 2025-06-25 | Fanapt | $28 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-25 | Caplyta | $12 |
| Teva Pharmaceuticals USA | Education · 2025-06-25 | None | $109 |
| Axsome Therapeutics | Meals · 2025-06-24 | Sunosi | $22 |
| Neurocrine BioSciences | Meals · 2025-06-20 | Ingrezza | $26 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-19 | Caplyta | $13 |
| Abbvie | Meals · 2025-06-18 | Vraylar | $7 |
| Alkermes | Meals · 2025-06-18 | Aristada | $7 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-18 | Caplyta | $6 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-18 | Caplyta | $1 |
| Abbvie | Meals · 2025-06-16 | Vraylar | $12 |
| Alkermes | Meals · 2025-06-12 | Aristada | $10 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-12 | Caplyta | $21 |
| Neurocrine BioSciences | Meals · 2025-06-12 | Ingrezza | $17 |
| Axsome Therapeutics | Meals · 2025-06-11 | Auvelity | $14 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-05 | Caplyta | $4 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-05 | Caplyta | $3 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-05 | Caplyta | $15 |
| Teva Pharmaceuticals USA | Meals · 2025-06-05 | Uzedy | $32 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-04 | Cobenfy | $10 |
| Harmony Biosciences | Meals · 2025-06-04 | Wakix | $39 |
| Abbvie | Meals · 2025-06-03 | Vraylar | $8 |
| Abbvie | Meals · 2025-06-02 | Vraylar | $9 |
| Alkermes | Meals · 2025-06-02 | Aristada | $8 |
| Alkermes | Meals · 2025-06-02 | Aristada | $2 |
| Axsome Therapeutics | Meals · 2025-05-30 | Auvelity | $32 |
| Vanda Pharmaceuticals | Meals · 2025-05-29 | Fanapt | $19 |
| Alkermes | Meals · 2025-05-28 | Aristada | $8 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-28 | Caplyta | $31 |
| Axsome Therapeutics | Meals · 2025-05-22 | Sunosi | $32 |
| Pfizer | Meals · 2025-05-21 | Nurtec Odt | $22 |
| Neurocrine BioSciences | Meals · 2025-05-20 | Ingrezza | $28 |
| Neurocrine BioSciences | Meals · 2025-05-20 | Ingrezza | $1 |
| Abbvie | Meals · 2025-05-19 | Vraylar | $15 |
| Neurocrine BioSciences | Meals · 2025-05-16 | Ingrezza | $14 |
| Axsome Therapeutics | Meals · 2025-05-15 | Auvelity | $22 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-15 | Caplyta | $16 |
| Abbvie | Meals · 2025-05-14 | Vraylar | $9 |
| Vanda Pharmaceuticals | Meals · 2025-05-14 | Fanapt | $36 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-12 | Cobenfy | $11 |
| Alkermes | Meals · 2025-05-09 | Aristada | $18 |
| Axsome Therapeutics | Meals · 2025-05-09 | Auvelity | $7 |
| Abbvie | Meals · 2025-05-07 | Vraylar | $9 |
| Otsuka America Pharmaceutical | Meals · 2025-05-07 | Rexulti | $28 |
| Vanda Pharmaceuticals | Meals · 2025-05-07 | Fanapt | $33 |
| Abbvie | Meals · 2025-05-06 | Vraylar | $7 |
| Pfizer | Meals · 2025-05-06 | Paxlovid | $2 |
| Pfizer | Meals · 2025-05-06 | Paxlovid | $10 |
| Vanda Pharmaceuticals | Meals · 2025-04-30 | Fanapt | $26 |
| Alkermes | Meals · 2025-04-28 | Aristada | $11 |
| Janssen Pharmaceuticals | Meals · 2025-04-24 | Invega Sustenna | $16 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-24 | Cobenfy | $12 |
| Axsome Therapeutics | Meals · 2025-04-24 | Auvelity | $34 |
| Vanda Pharmaceuticals | Meals · 2025-04-23 | Fanapt | $8 |
| Abbvie | Meals · 2025-04-22 | Vraylar | $8 |
| Neurocrine BioSciences | Meals · 2025-04-22 | Ingrezza | $16 |
| Abbvie | Meals · 2025-04-21 | Vraylar | $7 |
| Axsome Therapeutics | Meals · 2025-04-10 | Auvelity | $33 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-10 | Caplyta | $8 |
| Neurocrine BioSciences | Meals · 2025-04-10 | Ingrezza | $31 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-09 | Cobenfy | $13 |
| Pfizer | Meals · 2025-04-09 | Nurtec Odt | $20 |
| Alkermes | Meals · 2025-04-08 | Aristada | $13 |
| Abbvie | Meals · 2025-04-07 | Vraylar | $14 |
| Vanda Pharmaceuticals | Meals · 2025-04-02 | Fanapt | $6 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-01 | Cobenfy | $13 |
| Tris Pharma | Meals · 2025-03-27 | Dyanavel Xr | $12 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-27 | Caplyta | $12 |
| Neurocrine BioSciences | Meals · 2025-03-27 | Ingrezza | $14 |
| Axsome Therapeutics | Meals · 2025-03-26 | Auvelity | $25 |
| Alkermes | Meals · 2025-03-25 | Aristada | $11 |
| Abbvie | Meals · 2025-03-24 | Vraylar | $8 |
| Alkermes | Meals · 2025-03-19 | Aristada | $9 |
| Abbvie | Meals · 2025-03-17 | Vraylar | $8 |
| Axsome Therapeutics | Meals · 2025-03-17 | Auvelity | $35 |
| Tris Pharma | Meals · 2025-03-14 | Dyanavel Xr | $22 |
| Abbvie | Meals · 2025-03-11 | Vraylar | $8 |
| Alkermes | Meals · 2025-03-11 | Aristada | $11 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-10 | Caplyta | $6 |
| Pfizer | Meals · 2025-03-06 | Nurtec Odt | $24 |
| Alkermes | Meals · 2025-03-05 | Aristada | $11 |
| Neurocrine BioSciences | Meals · 2025-03-04 | Ingrezza | $35 |
| Abbvie | Meals · 2025-03-03 | Vraylar | $15 |
| Axsome Therapeutics | Meals · 2025-02-27 | Auvelity | $24 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-26 | Caplyta | $7 |
| Alkermes | Meals · 2025-02-25 | Aristada | $7 |
| Abbvie | Meals · 2025-02-24 | Vraylar | $20 |
| Tris Pharma | Meals · 2025-02-21 | Dyanavel Xr | $23 |
| Neurocrine BioSciences | Meals · 2025-02-21 | Ingrezza | $14 |
| Alkermes | Meals · 2025-02-19 | Aristada | $12 |
| Indivior | Meals · 2025-02-18 | Sublocade | $13 |
| Axsome Therapeutics | Meals · 2025-02-14 | Auvelity | $9 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-12 | Caplyta | $3 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-12 | Caplyta | $6 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-12 | Caplyta | $4 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-12 | Caplyta | $1 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-11 | Cobenfy | $22 |
| Alkermes | Meals · 2025-02-10 | Aristada | $13 |
| Abbvie | Meals · 2025-02-07 | Vraylar | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-06 | Cobenfy | $10 |
| Tris Pharma | Meals · 2025-02-06 | Dyanavel Xr | $27 |
| Otsuka America Pharmaceutical | Meals · 2025-02-04 | Rexulti | $7 |
| Abbvie | Meals · 2025-02-03 | Vraylar | $11 |
| Axsome Therapeutics | Meals · 2025-01-31 | Auvelity | $21 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-01-29 | Caplyta | $6 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-01-29 | Caplyta | $4 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-01-29 | Caplyta | $9 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-01-29 | Caplyta | $1 |
| Lundbeck | Meals · 2025-01-28 | Rexulti | $33 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-01-27 | Trintellix | $27 |
| Tris Pharma | Meals · 2025-01-22 | Dyanavel Xr | $22 |
| Alkermes | Meals · 2025-01-22 | Aristada | $11 |
| Tris Pharma | Meals · 2025-01-20 | Dyanavel Xr | $13 |
| Abbvie | Meals · 2025-01-18 | Vraylar | $29 |
| Alkermes | Meals · 2025-01-16 | Aristada | $14 |
| Abbvie | Meals · 2025-01-15 | Vraylar | $8 |
| Abbvie | Meals · 2025-01-15 | Qulipta | $13 |
| Axsome Therapeutics | Meals · 2025-01-15 | Auvelity | $7 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-01-15 | Caplyta | $34 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-09 | Cobenfy | $11 |
| Alkermes | Meals · 2025-01-08 | Aristada | $10 |
| Vanda Pharmaceuticals | Meals · 2025-01-08 | Fanapt | $12 |
| Otsuka America Pharmaceutical | Meals · 2025-01-07 | Rexulti | $8 |
| Abbvie | Meals · 2025-01-06 | Vraylar | $14 |
| Abbvie | Meals · 2025-01-02 | Vraylar | $9 |
See earlier years (2024, 2023, 2022, 2021)
2024: $2,888
| Abbvie | Vraylar | $720 | 54 payments
|
| Axsome Therapeutics | Auvelity | $557 | 24 payments
|
| Alkermes | Aristada | $466 | 28 payments
|
| Lundbeck | Abilify Asimtufii | $308 | 18 payments
|
| Otsuka America Pharmaceutical | Rexulti | $205 | 11 payments
|
| Tris Pharma | Dyanavel Xr | $177 | 15 payments
|
| Pfizer | Nurtec Odt | $125 | 6 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $78 | 3 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $73 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $55 | 2 payments
|
| Corium | Azstarys | $29 | 2 payments
|
| Indivior | Perseris | $29 | 1 payment
|
| Lilly USA | Mounjaro | $24 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $23 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $20 | 1 payment
|
2023: $2,313
| Abbvie | Vraylar | $806 | 51 payments
|
| Alkermes | Aristada | $432 | 22 payments
|
| Axsome Therapeutics | Auvelity | $294 | 20 payments
|
| Supernus Pharmaceuticals | Qelbree | $159 | 18 payments
|
| Iti | Caplyta | $158 | 9 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $100 | 5 payments
|
| Tris Pharma | Dyanavel Xr | $99 | 5 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $79 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $73 | 4 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $37 | 2 payments
|
| Sumitomo Pharma America | Latuda | $26 | 1 payment
|
| Braeburn | Brixadi | $18 | 1 payment
|
| Pfizer | Comirnaty | $16 | 1 payment
|
| Corium | Azstarys | $15 | 1 payment
|
2022: $2,029
| Abbvie | Vraylar | $500 | 38 payments
|
| Alkermes | Aristada | $466 | 21 payments
|
| Sunovion Pharmaceuticals | Latuda | $299 | 19 payments
|
| Iti | Caplyta | $151 | 8 payments
|
| Teva Pharmaceuticals USA | Austedo | $135 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $128 | 9 payments
|
| Janssen Pharmaceuticals | Spravato | $114 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $63 | 3 payments
|
| Supernus Pharmaceuticals | Qelbree | $45 | 2 payments
|
| Axsome Therapeutics | Auvelity | $45 | 2 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $23 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $23 | 1 payment
|
| Avanir Pharmaceuticals | Nuedexta | $20 | 1 payment
|
| Genentech USA | Venclexta | $16 | 1 payment
|
2021: $1,254
| AbbVie | Vraylar | $573 | 37 payments
|
| Sunovion Pharmaceuticals | Latuda | $283 | 17 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $209 | 15 payments
|
| Alkermes | Aristada | $75 | 4 payments
|
| Supernus Pharmaceuticals | Qelbree | $44 | 2 payments
|
| Lundbeck | Brintellix | $35 | 2 payments
|
| Eisai | None | $18 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1831195924
- Licence
- CA 11619California G11619: Cancelled
- Group
- Doctors on Duty Medical Group, Inc · Thinh Duy Mai MD Apc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 1212 S Main St, Salinas, CA, 93901
- NPI first listed
- 2005-06-22
- NPI last updated
- 2018-04-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 7130 N Millbrook Ave, Fresno, CA, 93720